Mylan (NASDAQ: MYL) issued the following statement regarding Abbott Laboratories' (NYSE: ABT) announced intention to support Mylan's offer to acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE